Aquestive therapeutics broadens patent estate for anaphylm™

Warren, n.j., oct. 08, 2025 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (“aquestive” or the “company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the united states patent and trademark office (uspto) has issued two additional u.s. patents related to anaphylm, the company's novel epinephrine prodrug sublingual film.
AQST Ratings Summary
AQST Quant Ranking